tiprankstipranks
Trending News
More News >
Lineage Cell Therapeutics, Inc. (LCTX)
:LCTX
US Market

Lineage Therap (LCTX) Income Statement

Compare
2,051 Followers

Lineage Therap Income Statement

Last quarter (Q3 2025), Lineage Therap's total revenue was $3.68M, a decrease of -2.59% from the same quarter last year. In Q3, Lineage Therap's net income was $-29.78M. See Lineage Therap’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 9.50M$ 8.95M$ 14.70M$ 3.90M$ 773.00K
Gross Profit
$ 9.16M$ 8.27M$ 13.97M$ 2.47M$ 388.00K
Operating Expenses
$ 30.64M$ 33.01M$ 36.49M$ 51.68M$ 26.84M
Depreciation and Amortization
$ 609.00K$ 692.00K$ 727.00K$ 873.00K$ 2.04M
EBITDA
$ -20.87M$ -24.04M$ -21.79M$ -48.34M$ -24.41M
Operating Income
$ -21.48M$ -24.73M$ -22.52M$ -49.21M$ -26.45M
Other Income/Expenses
$ 2.90M$ 1.45M$ -3.29M$ 5.94M$ 4.52M
Pretax Income
$ -18.58M$ -23.28M$ -25.81M$ -43.27M$ -21.92M
Net Income
$ -18.61M$ -21.49M$ -26.27M$ -43.02M$ -20.65M
Per Share Metrics
Basic EPS
$ -0.09$ -0.12$ -0.15$ -0.26$ -0.14
Diluted EPS
$ -0.09$ -0.12$ -0.15$ -0.26$ -0.14
Weighted Average Shares Outstanding
200.19M 172.66M 169.79M 164.50M 150.04M
Weighted Average Shares Outstanding (Diluted)
200.19M 172.66M 169.79M 164.50M 150.04M
Currency in USD

Lineage Therap Earnings and Revenue History